Dual blockade of epidermal growth factor receptor and insulin‐like growth factor receptor–1 signaling in metastatic pancreatic cancer: Phase Ib and randomized …
PA Philip, B Goldman, RK Ramanathan, HJ Lenz… - Cancer, 2014 - Wiley Online Library
BACKGROUND Targeting a single pathway in pancreatic adenocarcinoma (PC) is unlikely
to affect its natural history. We tested the hypothesis that simulataneous targeting of the …
to affect its natural history. We tested the hypothesis that simulataneous targeting of the …
Dual blockade of epidermal growth factor receptor and insulin-like growth factor receptor-1 signaling in metastatic pancreatic cancer: phase Ib and randomized phase …
PA Philip, B Goldman, RK Ramanathan, HJ Lenz… - Cancer, 2014 - ohsu.elsevierpure.com
Targeting a single pathway in pancreatic adenocarcinoma (PC) is unlikely to affect its
natural history. We tested the hypothesis that simulataneous targeting of the epidermal …
natural history. We tested the hypothesis that simulataneous targeting of the epidermal …
Dual blockade of epidermal growth factor receptor and insulin‐like growth factor receptor–1 signaling in metastatic pancreatic cancer: Phase Ib and randomized …
PA Philip, B Goldman, RK Ramanathan, HJ Lenz… - Cancer, 2014 - infona.pl
BACKGROUND Targeting a single pathway in pancreatic adenocarcinoma (PC) is unlikely
to affect its natural history. We tested the hypothesis that simulataneous targeting of the …
to affect its natural history. We tested the hypothesis that simulataneous targeting of the …
[HTML][HTML] Dual blockade of epidermal growth factor receptor (EGFR) and insulin-like growth factor receptor-1 (IGF-1R) signaling in metastatic pancreatic cancer: phase …
PA Philip, B Goldman, RK Ramanathan, HJ Lenz… - Cancer, 2014 - ncbi.nlm.nih.gov
Purpose Targeting a single pathway in pancreatic adenocarcinoma (PC) is unlikely to
impact its natural history. We tested the hypothesis that simulataneous targeting of the EGFR …
impact its natural history. We tested the hypothesis that simulataneous targeting of the EGFR …
Dual blockade of epidermal growth factor receptor and insulin-like growth factor receptor-1 signaling in metastatic pancreatic cancer: phase Ib and randomized phase …
PA Philip, B Goldman, RK Ramanathan… - …, 2014 - mayoclinic.pure.elsevier.com
Targeting a single pathway in pancreatic adenocarcinoma (PC) is unlikely to affect its
natural history. We tested the hypothesis that simulataneous targeting of the epidermal …
natural history. We tested the hypothesis that simulataneous targeting of the epidermal …
Dual blockade of epidermal growth factor receptor and insulin-like growth factor receptor-1 signaling in metastatic pancreatic cancer: phase Ib and randomized phase …
PA Philip, B Goldman, RK Ramanathan… - …, 2014 - mayoclinic.elsevierpure.com
Targeting a single pathway in pancreatic adenocarcinoma (PC) is unlikely to affect its
natural history. We tested the hypothesis that simulataneous targeting of the epidermal …
natural history. We tested the hypothesis that simulataneous targeting of the epidermal …
Dual blockade of epidermal growth factor receptor and insulin-like growth factor receptor-1 signaling in metastatic pancreatic cancer: phase Ib and randomized phase …
PA Philip, B Goldman, RK Ramanathan, HJ Lenz… - Cancer, 2014 - europepmc.org
Background Targeting a single pathway in pancreatic adenocarcinoma (PC) is unlikely to
affect its natural history. We tested the hypothesis that simulataneous targeting of the …
affect its natural history. We tested the hypothesis that simulataneous targeting of the …
Dual blockade of epidermal growth factor receptor and insulin-like growth factor receptor-1 signaling in metastatic pancreatic cancer: phase Ib and randomized phase …
PA Philip, B Goldman, RK Ramanathan, HJ Lenz… - Cancer, 2014 - pubmed.ncbi.nlm.nih.gov
Background Targeting a single pathway in pancreatic adenocarcinoma (PC) is unlikely to
affect its natural history. We tested the hypothesis that simulataneous targeting of the …
affect its natural history. We tested the hypothesis that simulataneous targeting of the …